Wall Street brokerages predict that Axcelis Technologies Inc (NASDAQ:ACLS) will announce sales of $97.37 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Axcelis Technologies’ earnings, with estimates ranging from $97.10 million to $97.50 million. Axcelis Technologies reported sales of $104.48 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 6.8%. The business is expected to report its next quarterly earnings results on Thursday, November 1st.

According to Zacks, analysts expect that Axcelis Technologies will report full year sales of $450.00 million for the current fiscal year. For the next fiscal year, analysts expect that the company will post sales of $498.87 million, with estimates ranging from $490.00 million to $511.60 million. Zacks’ sales averages are an average based on a survey of research firms that cover Axcelis Technologies.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Thursday, August 2nd. The semiconductor company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.08. The company had revenue of $119.30 million during the quarter, compared to analysts’ expectations of $116.33 million. Axcelis Technologies had a net margin of 28.57% and a return on equity of 16.84%. The firm’s revenue for the quarter was up 16.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.42 EPS.

A number of equities analysts have weighed in on ACLS shares. BidaskClub cut shares of Axcelis Technologies from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 18th. Needham & Company LLC reissued a “buy” rating and issued a $27.00 price objective on shares of Axcelis Technologies in a research report on Friday, August 3rd. Craig Hallum raised shares of Axcelis Technologies from a “hold” rating to a “buy” rating in a research report on Friday, August 3rd. Benchmark reissued a “buy” rating and issued a $32.00 price objective on shares of Axcelis Technologies in a research report on Friday, August 3rd. Finally, ValuEngine raised shares of Axcelis Technologies from a “sell” rating to a “hold” rating in a research report on Friday, August 3rd. One analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the stock. Axcelis Technologies currently has a consensus rating of “Buy” and a consensus price target of $29.50.

Several hedge funds have recently modified their holdings of ACLS. Mount Yale Investment Advisors LLC bought a new position in shares of Axcelis Technologies during the first quarter worth about $143,000. Piedmont Investment Advisors LLC bought a new position in shares of Axcelis Technologies during the second quarter worth about $148,000. Bank of Montreal Can bought a new position in shares of Axcelis Technologies during the second quarter worth about $161,000. Metropolitan Life Insurance Co. NY lifted its position in shares of Axcelis Technologies by 362.2% during the second quarter. Metropolitan Life Insurance Co. NY now owns 10,363 shares of the semiconductor company’s stock worth $205,000 after purchasing an additional 8,121 shares during the last quarter. Finally, LSV Asset Management bought a new position in shares of Axcelis Technologies during the second quarter worth about $209,000. 84.59% of the stock is currently owned by institutional investors and hedge funds.

NASDAQ:ACLS traded down $0.30 on Friday, reaching $19.85. The stock had a trading volume of 3,511 shares, compared to its average volume of 290,343. The stock has a market cap of $655.20 million, a P/E ratio of 13.55 and a beta of 0.85. Axcelis Technologies has a 12-month low of $18.35 and a 12-month high of $37.05.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. The company offers a line of high energy, high current, and medium current implanters for various application requirements. It also provides dry strip equipment, curing systems, and thermal processing systems.

Featured Article: How much money do you need to begin day trading?

Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.